MagForce AG is a pioneer in the area of nanotechnology-based cancer treatment. It is the first company in the world to receive European approval for a medical product using nanoparticles. In Germany, this innovative therapy is available to patients at the NanoTherm therapy centers at the Charite-Universitats- medizin hospital in Berlin, and the university hospitals Munster, Kiel, Cologne and Frankfurt. Additional therapy centers in Germany are planned.